MedPath

Putting CDSMP to Work

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Chronic Disease
Interventions
Behavioral: Workplace-tailored CDSMP
Behavioral: Chronic Disease Self-Management Program
Registration Number
NCT02409056
Lead Sponsor
University of Georgia
Brief Summary

This project is the test of the effectiveness of the Chronic Disease Self-Management Program which will be translated to a worksite setting.

Detailed Description

This project will test adaptations of the Chronic Disease Self-Management Program (CDSMP) designed to increase the likelihood of widespread use in workplace settings. CDSMP, which has been proven efficacious in community trials, is a six-week program that is designed to help individuals better manage their chronic disease and its many complications. Although there is considerable interest among worksite health promotion practitioners for a chronic disease program, CDSMP has not been adapted and tested in workplace settings. In this study, we will determine a) if the CDSMP program tailored to worksites can be efficacious, b) the comparative effectiveness of the worksite tailored CDSMP when compared to the original CDSMP and c) the cost-effectiveness (average and incremental) and return on investment of the two interventions. The participating sites are seven organizations from a rural county in Southwest Georgia. Our partner for the project is the local YMCA. YMCA staff will be trained to implement the program which will foster sustainability. Participants will be randomly assigned to 1) workplace-tailored CDSMP, 2) 'usual care' CDSMP, and 3) control group. Data will collected at baseline, 6-month follow-up and 12-months follow-up. The control group will be a delayed intervention group that will be randomly assigned to an intervention group after taking the 6 month survey. The primary outcome measures include blood pressure, cholesterol, blood glucose, BMI, diet, physical activity and tobacco use and the secondary measures including patient-provider communication, quality of life, medical adherence, and work performance and productivity. An average cost-effectiveness analysis will compare interventions to control and an incremental cost-effectiveness analysis will be conducted comparing each intervention to one another. The hypotheses will be tested using a growth modeling approach examining changes over time. This will enable us to maximize the dissemination and implementation of CDSMP across worksite populations by using approaches which are realistic for most work organizations.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
800
Inclusion Criteria
  • The primary target is all employees 45 years or above with levels of gender and ethnicity similar to those found in the workplaces with which we will work.
  • If younger individuals wish to participate, we will not turn them away but the program is designed for older adults. It is unlikely we will get a substantial number of participants over 45.
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
workplace-tailored CDSMPWorkplace-tailored CDSMPGroup will receive the CDSMP program which has been modified to fit the unique characteristics of the workplace.
CDSMP usual careChronic Disease Self-Management ProgramGroup will receive the standard CDSMP program which is currently being offered in a variety of community settings.
Primary Outcome Measures
NameTimeMethod
blood glucose examining change at 6 and 12 monthsbaseline, six months, one year

blood glucose levels

Cholesterol levels examining change at 6 and 12 monthsbaseline, six months, one year

HDL, LDL, and total cholesterol levels

Cardiovascular risk scale examining change at 6 and 12 monthsbaseline, six months, one year

Overall measure taken from the Framing Heart Study which includes: systolic blood pressure, total cholesterol, HDL cholesterol, BMI, gender, age, use of antihypertensive treatment, smoking and diabetes mellitus status.

Physical activity (Measure of moderate-intensity physical activities) examining change at 6 and 12 monthsbaseline, six months, one year

Measure of moderate-intensity physical activities.

Sedentary behavior (Measures total time spent sitting in transport, work and leisure) examining change at 6 and 12 monthsbaseline, six months, one year

Measures total time spent sitting in transport, work and leisure.

Eating behaviors (Food propensity questionnaire) examining change at 6 and 12 monthsbaseline, six months, one year

Food propensity questionnaire used to estimate usual intake for food items and food groups.

Body Mass Index examining change at 6 and 12 monthsbaseline, six months, one year

Measure of obesity using height and weight

Tobacco use examining change at 6 and 12 monthsbaseline, six months, one year

Measure of current and past tobacco use.

blood pressure examining change at 6 and 12 monthsbaseline, six months, one year

diastolic and systolic measures

Secondary Outcome Measures
NameTimeMethod
Patient-provider communication (Measure of communication with a physician) examining change at 6 and 12 monthsbaseline, six months, one year

Measure of communication with a physician.

Self-assessed quality of life scale examining change at 6 and 12 monthsbaseline, six months, one year

CDC Healthy Days quality of life measure.

Sleep (Visual analogue scale) examining change at 6 and 12 monthsbaseline, six months, one year

Visual analogue scale to determine symptoms of chronic disease.

Fatigue (Visual analogue scale) examining change at 6 and 12 monthsbaseline, six months, one year

Visual analogue scale to determine symptoms of chronic disease.

Quality of life (EQ-5D) scale examining change at 6 and 12 monthsbaseline, six months, one year

Measure of quality of life (EQ-5D).

Prescription medication adherence examining change at 6 and 12 monthsbaseline, six months, one year

Measures medication compliance.

Stress (Visual analogue scale) examining change at 6 and 12 monthsbaseline, six months, one year

Visual analogue scale to determine symptoms of chronic disease.

Well-being (SF-12) scale examining change at 6 and 12 monthsbaseline, six months, one year

Measure of functional health and well-being (SF-12).

Depression (Personal Health Questionnaire Depression Scale (PHQ8) examining change at 6 and 12 monthsbaseline, six months, one year

Personal Health Questionnaire Depression Scale (PHQ8).

Pain (Visual analogue scale) examining change at 6 and 12 monthsbaseline, six months, one year

Visual analogue scale to determine symptoms of chronic disease.

Trial Locations

Locations (13)

Colquitt Regional Medical Center

🇺🇸

Moultrie, Georgia, United States

National Beef

🇺🇸

Moultrie, Georgia, United States

City of Moultrie

🇺🇸

Moultrie, Georgia, United States

Colquitt County Schools

🇺🇸

Moultrie, Georgia, United States

Wiregrass Technical College

🇺🇸

Valdosta, Georgia, United States

Southwest Georgia Community Action Council

🇺🇸

Moultrie, Georgia, United States

Lowndes County

🇺🇸

Valdosta, Georgia, United States

Southwest Georgia Bank

🇺🇸

Moultrie, Georgia, United States

Southwest Regional Technical College

🇺🇸

Moultrie, Georgia, United States

Madison County Schools

🇺🇸

Danielsville, Georgia, United States

Colquitt County Government

🇺🇸

Moultrie, Georgia, United States

Turning Point Hospital

🇺🇸

Moultrie, Georgia, United States

Valdosta City Schools

🇺🇸

Valdosta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath